UNSPSC 85813004: Introduction of other diagnostic substance into genitourinary tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other diagnostic substance into genitourinary tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0K3KZ

UNSPSC 85813004 Introduction of other diagnostic substance into genitourinary tract, percutaneous approach (Commodity) shows minimal alignment with the recent state and local procurement activity captured under this code. The opportunities posted under the code span virtual urgent care, occupational health services, PACE operations, rural value-based care facilitation, cancer registry services, retinal screening devices, EMS staffing, employee health clinics, psychological evaluations, wellness programs, and opioid treatment initiatives—none of which involve genitourinary diagnostic procedures. State and local buyers posting against this code include health plans, counties, cities, school districts, behavioral health departments, and cooperative purchasing consortia across California, Georgia, Nevada, Colorado, Florida, Kansas, Texas, and Washington, issuing RFPs, RFQs, and RFIs with response deadlines ranging from late September 2026 through October 2027. The code's nominal scope—a clinical procedure category—does not match the operational health services and program administration work actually being solicited.

The mismatch between code taxonomy and procurement activity reflects either miscoding by issuing bodies or a data artifact where state and local procurement systems tagged unrelated health services under a medical procedure code. Representative recent solicitations—Inland Empire Health Plan's RFI for 24/7 virtual urgent care (October 31, 2026 response deadline), Nevada Health Authority's RFP for PACE operations (December 10, 2026), and San Mateo Medical Center's RFP for cancer registry services (October 12, 2026)—are grounded in clinical delivery models, case management, and administrative support rather than genitourinary diagnostics. Pursuit under this code would require clarification from issuing bodies on actual scope intent, as the code's stated meaning bears no relation to the services state and local governments are actively buying.